MedX Health Corp (MDXHF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 5.64 Million CAD | 16.29% |
| 2022 | 4.85 Million CAD | 96.25% |
| 2021 | 2.47 Million CAD | 171.57% |
| 2020 | 910.98 Thousand CAD | 18.97% |
| 2019 | 765.75 Thousand CAD | 54.68% |
| 2018 | 495.06 Thousand CAD | -21.03% |
| 2017 | 626.88 Thousand CAD | 10.56% |
| 2016 | 566.98 Thousand CAD | -36.53% |
| 2015 | 893.25 Thousand CAD | 1090.66% |
| 2014 | 75.02 Thousand CAD | 539.96% |
| 2013 | 11.72 Thousand CAD | -98.75% |
| 2012 | 934.46 Thousand CAD | -0.49% |
| 2011 | 939.06 Thousand CAD | 19.88% |
| 2010 | 783.3 Thousand CAD | 2.73% |
| 2009 | 762.48 Thousand CAD | -2.32% |
| 2008 | 780.57 Thousand CAD | -70.22% |
| 2007 | 2.62 Million CAD | 277.75% |
| 2006 | 693.94 Thousand CAD | -53.59% |
| 2005 | 1.49 Million CAD | 24.75% |
| 2004 | 1.19 Million CAD | 568.36% |
| 2003 | 179.31 Thousand CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 6.21 Million CAD | 10.04% |
| 2024 Q2 | 6.47 Million CAD | 4.27% |
| 2023 Q3 | 5.64 Million CAD | 0.61% |
| 2023 Q4 | 5.64 Million CAD | 0.01% |
| 2023 Q2 | 5.61 Million CAD | 23.68% |
| 2023 Q1 | 4.53 Million CAD | -6.55% |
| 2023 FY | 5.64 Million CAD | 16.29% |
| 2022 Q4 | 4.85 Million CAD | 25.53% |
| 2022 Q1 | 2.89 Million CAD | 17.03% |
| 2022 Q2 | 3.31 Million CAD | 14.43% |
| 2022 FY | 4.85 Million CAD | 96.25% |
| 2022 Q3 | 3.86 Million CAD | 16.73% |
| 2021 Q2 | 1.96 Million CAD | 19.42% |
| 2021 Q4 | 2.47 Million CAD | -14.48% |
| 2021 FY | 2.47 Million CAD | 171.57% |
| 2021 Q1 | 1.64 Million CAD | 80.23% |
| 2021 Q3 | 2.89 Million CAD | 47.53% |
| 2020 Q1 | 609.75 Thousand CAD | -20.37% |
| 2020 Q4 | 910.98 Thousand CAD | 143.52% |
| 2020 FY | 910.98 Thousand CAD | 18.97% |
| 2020 Q2 | 66.99 Thousand CAD | -89.01% |
| 2020 Q3 | 374.08 Thousand CAD | 458.35% |
| 2019 Q4 | 765.75 Thousand CAD | 12.05% |
| 2019 FY | 765.75 Thousand CAD | 54.68% |
| 2019 Q3 | 683.41 Thousand CAD | 8.95% |
| 2019 Q2 | 627.28 Thousand CAD | 9.97% |
| 2019 Q1 | 570.41 Thousand CAD | 15.22% |
| 2018 FY | 495.06 Thousand CAD | -21.03% |
| 2018 Q2 | -63.16 Thousand CAD | 89.43% |
| 2018 Q1 | -597.77 Thousand CAD | -195.36% |
| 2018 Q3 | 446.37 Thousand CAD | 806.7% |
| 2018 Q4 | 495.06 Thousand CAD | 10.91% |
| 2017 FY | 626.88 Thousand CAD | 10.56% |
| 2017 Q1 | 827.22 Thousand CAD | 45.9% |
| 2017 Q2 | 644.65 Thousand CAD | -22.07% |
| 2017 Q4 | 626.88 Thousand CAD | -13.45% |
| 2017 Q3 | 724.31 Thousand CAD | 12.36% |
| 2016 FY | 566.98 Thousand CAD | -36.53% |
| 2016 Q4 | 566.98 Thousand CAD | 49.11% |
| 2016 Q3 | 380.25 Thousand CAD | -58.87% |
| 2016 Q1 | 949.66 Thousand CAD | 6.32% |
| 2016 Q2 | 924.49 Thousand CAD | -2.65% |
| 2015 Q4 | 893.25 Thousand CAD | 41.97% |
| 2015 Q3 | 629.19 Thousand CAD | 288.12% |
| 2015 Q2 | 162.11 Thousand CAD | 3.93% |
| 2015 Q1 | 155.99 Thousand CAD | 107.93% |
| 2015 FY | 893.25 Thousand CAD | 1090.66% |
| 2014 FY | 75.02 Thousand CAD | 539.96% |
| 2014 Q3 | 68.79 Thousand CAD | 1801.85% |
| 2014 Q4 | 75.02 Thousand CAD | 9.06% |
| 2014 Q2 | 3617.00 CAD | 117.52% |
| 2014 Q1 | -20.64 Thousand CAD | -276.11% |
| 2013 Q3 | 878.61 Thousand CAD | -20.08% |
| 2013 Q2 | 1.09 Million CAD | 16.03% |
| 2013 Q1 | 947.5 Thousand CAD | 1.4% |
| 2013 Q4 | 11.72 Thousand CAD | -98.67% |
| 2013 FY | 11.72 Thousand CAD | -98.75% |
| 2012 Q2 | 1.01 Million CAD | 2.18% |
| 2012 Q3 | 314.59 Thousand CAD | -69.08% |
| 2012 Q4 | 934.46 Thousand CAD | 197.04% |
| 2012 FY | 934.46 Thousand CAD | -0.49% |
| 2012 Q1 | 995.59 Thousand CAD | 6.02% |
| 2011 Q3 | 937.03 Thousand CAD | 8.38% |
| 2011 FY | 939.06 Thousand CAD | 19.88% |
| 2011 Q4 | 939.06 Thousand CAD | 0.22% |
| 2011 Q2 | 864.6 Thousand CAD | 10.41% |
| 2011 Q1 | 783.06 Thousand CAD | -0.03% |
| 2010 Q2 | 779.39 Thousand CAD | 1.56% |
| 2010 Q4 | 783.3 Thousand CAD | 0.5% |
| 2010 FY | 783.3 Thousand CAD | 2.73% |
| 2010 Q3 | 779.39 Thousand CAD | 0.0% |
| 2010 Q1 | 767.38 Thousand CAD | 0.64% |
| 2009 Q3 | 782.62 Thousand CAD | 2.76% |
| 2009 Q4 | 762.48 Thousand CAD | -2.57% |
| 2009 Q1 | 775.5 Thousand CAD | -0.65% |
| 2009 FY | 762.48 Thousand CAD | -2.32% |
| 2009 Q2 | 761.6 Thousand CAD | -1.79% |
| 2008 Q1 | -189.18 Thousand CAD | -107.22% |
| 2008 Q2 | 833.17 Thousand CAD | 540.4% |
| 2008 FY | 780.57 Thousand CAD | -70.22% |
| 2008 Q3 | 448.1 Thousand CAD | -46.22% |
| 2008 Q4 | 780.57 Thousand CAD | 74.19% |
| 2007 Q1 | 1.24 Million CAD | 78.81% |
| 2007 Q2 | 2.19 Million CAD | 76.68% |
| 2007 Q3 | 2.37 Million CAD | 8.26% |
| 2007 Q4 | 2.62 Million CAD | 10.45% |
| 2007 FY | 2.62 Million CAD | 277.75% |
| 2006 Q3 | 1.79 Million CAD | 14.93% |
| 2006 Q4 | 693.94 Thousand CAD | -61.26% |
| 2006 Q2 | 1.55 Million CAD | 3.83% |
| 2006 Q1 | 1.5 Million CAD | 0.39% |
| 2006 FY | 693.94 Thousand CAD | -53.59% |
| 2005 Q2 | 694.55 Thousand CAD | 96.94% |
| 2005 Q4 | 1.49 Million CAD | 18.55% |
| 2005 Q3 | 1.26 Million CAD | 81.57% |
| 2005 Q1 | 352.67 Thousand CAD | -70.57% |
| 2005 FY | 1.49 Million CAD | 24.75% |
| 2004 Q4 | 1.19 Million CAD | 0.0% |
| 2004 FY | 1.19 Million CAD | 568.36% |
| 2003 FY | 179.31 Thousand CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AVITA Medical, Inc. | -26.23 Million USD | 121.524% |
| Manhattan Scientifics, Inc. | -7000.00 USD | 80758.443% |
| Össur hf. | 395.08 Million USD | 98.571% |
| QHSLab, Inc. | 1.72 Million USD | -226.369% |
| Wellstar International, Inc. | 51.36 Million USD | 89.008% |
| Össur hf. | 395.08 Million USD | 98.571% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 315.68 Thousand USD | -1688.515% |
| Aurora Spine Corporation | 1.9 Million USD | -195.97% |
| BrainsWay Ltd. | -10.32 Million USD | 154.71% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | 14.82 Million USD | 61.919% |
| Hamilton Thorne Ltd. | 18.12 Million USD | 68.851% |
| Vivos Inc. | -1.59 Million USD | 454.59% |
| Kelyniam Global, Inc. | 487.33 Thousand USD | -1058.569% |
| REMSleep Holdings, Inc. | -540.98 Thousand USD | 1143.667% |
| Zecotek Photonics Inc. | 2.76 Million USD | -104.387% |
| Avitar, Inc. | 5.17 Million USD | -9.184% |
| Nanomix Corporation | 11.38 Million USD | 50.426% |
| EKF Diagnostics Holdings plc | -4.61 Million USD | 222.285% |
| Theraclion SA | -5.86 Million EUR | 196.275% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | 1.68 Million USD | -234.706% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.61 Million USD | -250.506% |
| Lombard Medical, Inc. | 11.49 Million USD | 50.882% |
| ALR Technologies Inc. | 19.14 Million USD | 70.514% |
| Stratec SE | 119.12 Million USD | 95.26% |
| Vycor Medical, Inc. | 1.05 Million USD | -436.213% |
| Heart Tronics, Inc. | 54.99 Thousand USD | -10166.553% |
| MicroPort Scientific Corporation | 673.58 Million USD | 99.162% |
| VMS Rehab Systems, Inc. | 133.52 USD | -4228548.143% |
| NewCardio, Inc. | 2.41 Million USD | -133.79% |
| Guided Therapeutics, Inc. | 1.46 Million USD | -284.874% |
| Ingen Technologies, Inc. | 630.91 Thousand USD | -794.9% |
| Odyssey Group International, Inc. | 2.1 Million USD | -167.867% |
| CYduct Diagnostics, Inc. | 640.19 Thousand USD | -781.93% |
| Wellness Center USA, Inc. | 3.98 Million USD | -41.666% |
| SANUWAVE Health, Inc. | 30.14 Million USD | 81.271% |
| IR-Med Inc. | -606 Thousand USD | 1031.698% |
| Perimeter Medical Imaging AI, Inc. | -13.78 Million USD | 140.951% |
| Polarean Imaging plc | -5.94 Million USD | 194.948% |
| United American Healthcare Corporation | -9.32 Million USD | 160.535% |
| ECGI Holdings, Inc. | 3.17 Million USD | -78.04% |
| Nu-Med Plus, Inc. | 93.19 Thousand USD | -5958.428% |
| Capital Group Holdings, Inc. | -3508.00 USD | 161049.002% |
| ADM Tronics Unlimited, Inc. | 262.61 Thousand USD | -2049.925% |
| Medical Supply International USA, Inc. | 216.6 Thousand USD | -2506.594% |
| Urologix, Inc. | 4.61 Million USD | -22.342% |
| Rapid Therapeutic Science Laboratories, Inc. | 4.2 Million USD | -34.13% |
| Nexeon MedSystems Inc. | 3.33 Million USD | -69.489% |
| SS Innovations International, Inc. | 1.18 Million USD | -376.325% |
| Qualis Innovations, Inc. | 6671.00 USD | -84536.351% |
| Smith & Nephew plc | 2.77 Billion USD | 99.797% |
| NIOX Group Plc | -23.93 Million USD | 123.592% |
| Fuse Medical, Inc. | 1.75 Million USD | -221.624% |
| Broncus Holding Corporation | -81.42 Million USD | 106.934% |
| Brain Scientific Inc. | 2.11 Million USD | -166.857% |
| Pressure BioSciences, Inc. | 22.67 Million USD | 75.102% |
| Health Logic Interactive Inc. | 39.55 Thousand USD | -14173.304% |